Literature DB >> 16292087

Longitudinal trends of stomach cancer and esophageal cancer in Yangzhong County: a high-incidence rural area of China.

Jian-Ming Wang1, Biao Xu, Chung-Cheng Hsieh, Qing-Wu Jiang.   

Abstract

OBJECTIVE: This study aims to investigate the recent trends in incidence rates of stomach cancer and esophageal cancer in a high-incidence rural area of China.
METHODS: All new cancer occurrences registered between 1991 and 2003 in the Yangzhong Cancer Registry were reviewed. Yearly age-specific and age-adjusted incidence rates were calculated for males and for females. Longitudinal trends of cancer incidence were estimated by the estimated annual percentage change method.
RESULTS: In total 12 691 incident cancer cases were registered, with 7159 males (56.41%) and 5532 females (43.59%). Adjusting to the world standard population, the incidence rate of all cancers decreased significantly across the period 1991-2003 from 357.02 to 283.21 per 10 person-years. For males this rate decreased from 447.22 to 346.72 per 10 person-years, and for females the incidence rate decreased from 284.36 to 225.73 per 10 person-years. The major cancers in Yangzhong County were stomach cancer and esophageal cancer, accounting for more than 70% of all cancer occurrences. During the past 13 years, the incidence rates of stomach cancer decreased greatly from 231.92 to 145.26 per 10 person-years in males and from 114.16 to 74.59 per 10 person-years in females. The estimated annual percentage changes of stomach cancer incidence were -2.96% [95% confidence interval (CI), -2.99% to -2.92%] in males and -2.86% (95% CI, -2.89% to -2.82%) in females. Incidence rates for esophageal cancer decreased slightly from 121.48 to 93.84 per 10 person-years in males with an estimated annual percentage change of -1.39% (95% CI, -1.42% to -1.36%), and from 99.74 to 73.73 per 10 person-years in females at an annual change of -2.18% (95% CI, -2.22% to -2.14%).
CONCLUSION: Findings from this study showed that, although there is a decreasing trend of stomach cancer and esophageal cancer in this high-incidence area, the rates remain high. Future effort should be directed toward identifying factors behind the high rates and those contributing to the decreasing trend.

Entities:  

Mesh:

Year:  2005        PMID: 16292087     DOI: 10.1097/00042737-200512000-00012

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010.

Authors:  Jing-Jing Jing; Hui-Yuan Liu; Jin-Kuan Hao; Li-Na Wang; Yun-Ping Wang; Li-Hua Sun; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

2.  Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely high-risk area in China.

Authors:  Min Su; Min Liu; Dong-Ping Tian; Xiao-Yun Li; Guo-Hong Zhang; He-Lin Yang; Xiaolong Fan; Hai-Hua Huang; Yu-Xia Gao
Journal:  Eur J Epidemiol       Date:  2006-12-29       Impact factor: 8.082

3.  Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.

Authors:  Ruyi Xia; Hongmei Zeng; Wenjun Liu; Li Xie; Mingwang Shen; Peng Li; He Li; Wenqiang Wei; Wanqing Chen; Guihua Zhuang
Journal:  JAMA Netw Open       Date:  2021-08-02

4.  Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma.

Authors:  Cheng Lu; Hui Xie; Fengliang Wang; Hongbing Shen; Jianming Wang
Journal:  BMC Cancer       Date:  2011-03-05       Impact factor: 4.430

5.  Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China.

Authors:  Xianzhi Zheng; Xuhua Mao; Kun Xu; Lingshuang Lü; Xianzhen Peng; Min Wang; Guisheng Xu; Zhaolai Hua; Jianping Wang; Hengchuan Xue; Jianming Wang; Cheng Lu
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

6.  Accumulated promoter methylation as a potential biomarker for esophageal cancer.

Authors:  Xianzhen Peng; Hengchuan Xue; Lingshuang Lü; Peiyi Shi; Jianping Wang; Jianming Wang
Journal:  Oncotarget       Date:  2017-01-03

7.  Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013.

Authors:  Zhaolai Hua; Xianzhi Zheng; Hengchuan Xue; Jianming Wang; Jun Yao
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

8.  Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study.

Authors:  Shuxia Qin; Xuehong Wang; Sini Li; Chongqing Tan; Xiaohui Zeng; Meiyu Wu; Ye Peng; Liting Wang; Xiaomin Wan
Journal:  Front Public Health       Date:  2022-08-10

9.  The survival and the long-term trends of patients with gastric cancer in Shanghai, China.

Authors:  Leizhen Zheng; Chunxiao Wu; Pan Xi; Meiling Zhu; Li Zhang; Siyu Chen; Xiaoping Li; Jianchun Gu; Ying Zheng
Journal:  BMC Cancer       Date:  2014-04-29       Impact factor: 4.430

10.  Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer.

Authors:  Huan-Qiang Wang; Cong-Ying Yang; Si-Yuan Wang; Tian Wang; Jing-Ling Han; Kai Wei; Fu-Cun Liu; Ji-da Xu; Xian-Zhen Peng; Jian-Ming Wang
Journal:  J Biomed Res       Date:  2018-11-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.